Search Results 211-220 of 690 for 원엑스벳1XBET

1. A Study Of APG-2575 Alone Or In Combination With Other Therapeutic Agents To Treat Relapsed And/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

   A Study Of APG-2575 Alone Or In Combination With Other Therapeutic Agents To Treat Relapsed And/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...

2. Ibrutinib, Lenalidomide, And Dexamethasone In Treating Patients With Multiple Myeloma Ineligible For Transplant - Mayo Clinic

   Ibrutinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as lenalidomide and ...

3. Phase 3 Study To Treat Patients With Soft Tissue Sarcomas - Mayo Clinic

   The purpose of this study is to determine the efficacy and safety of aldoxorubicin in subjects with metastatic, locally advanced, or unresectable soft tissue ...

4. A Study Of PY314 In Subjects With Advanced Solid Tumors - Mayo Clinic

   About this study. A Phase 1a/1b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PY314 as a Single Agent and ...

5. Academics - Find a Program at Mayo Clinic College of Medicine & Science

   Search the more than 400 medical, surgical, health sciences, and biomedical research training programs at Mayo Clinic College of Medicine and Science.

6. Effects of Aprepitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying - Mayo Clinic

   This research study is being done to compare the effects of Aprepitant and placebo on fasting gastric volume, accommodation volume, satiation (fullness) and ...

7. Factor ix (intravenous route, injection route) - Side effects & dosage - Mayo Clinic

   It helps the blood form clots to stop bleeding. Injections of factor IX are used to treat hemophilia B, which is sometimes called Christmas disease. This is a ...

8. Dose Escalation And Expansion Study Of GSK525762 In Combination With Fulvestrant In Subjects With Estrogen Receptor Positive (ER+) Breast Cancer - Mayo Clinic

   This is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with advanced or metastatic ER+ ...

9. A Study To Evaluate CTX110 In Subjects With Relapsed Or Refractory B-Cell Malignancies - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

10. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Bevacizumab blocks the ability of tumors to grow new blood vessels and ...